Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10721 (
c-kit
)
6,575
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cysteinyl leukotrienes (cys-LTs) induce inflammation through 2 G protein-coupled receptors (GPCRs), CysLT(1) and
CysLT(2)
, which are coexpressed by most myeloid cells. Cys-LTs induce proliferation of mast cells (MCs), transactivate
c-Kit
, and phosphorylate extracellular signal-regulated kinase (ERK). Although MCs express
CysLT(2)
, their responses to cys-LTs are blocked by antagonists of CysLT(1). We demonstrate that
CysLT(2)
interacts with CysLT(1), and that knockdown of
CysLT(2)
increases CysLT(1) surface expression and CysLT(1)-dependent proliferation of cord blood-derived human MCs (hMCs). Cys-LT-mediated responses were absent in MCs from mice lacking CysLT(1) receptors, but enhanced by the absence of
CysLT(2)
receptors. CysLT(1) and
CysLT(2)
receptors colocalized to the plasma membranes and nuclei of a human MC line, LAD2. Antibody-based fluorescent lifetime imaging microscopy confirmed complexes containing both receptors based on fluorescence energy transfer. Negative regulation of CysLT(1)-induced mitogenic signaling responses of MCs by
CysLT(2)
demonstrates physiologically relevant functions for GPCR heterodimers on primary cells central to inflammation.
...
PMID:CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. 1769 79